| PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery P Milla, F Dosio, L Cattel Current drug metabolism 13 (1), 105-119, 2012 | 465 | 2012 |
| Systematic analysis of yeast strains with possible defects in lipid metabolism G Daum, G Tuller, T Nemec, C Hrastnik, G Balliano, L Cattel, P Milla, ... Yeast 15 (7), 601-614, 1999 | 191 | 1999 |
| Hyaluronic acid conjugates as vectors for the active targeting of drugs, genes and nanocomposites in cancer treatment S Arpicco, P Milla, B Stella, F Dosio Molecules 19 (3), 3193-3230, 2014 | 131 | 2014 |
| Yeast oxidosqualene cyclase (Erg7p) is a major component of lipid particles P Milla, K Athenstaedt, F Viola, S Oliaro-Bosso, SD Kohlwein, G Daum, ... Journal of Biological Chemistry 277 (4), 2406-2412, 2002 | 95 | 2002 |
| Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity P Milla, M Airoldi, G Weber, A Drescher, U Jaehde, L Cattel Anti-cancer drugs 20 (5), 396-402, 2009 | 87 | 2009 |
| EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers F Dosio, P Milla, L Cattel Curr Opin Investig Drugs 11 (12), 1424-1433, 2010 | 73 | 2010 |
| Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene‐hopene cyclases M Ceruti, G Balliano, F Rocco, P Milla, S Arpicco, L Cattel, F Viola Lipids 36 (6), 629-636, 2001 | 72 | 2001 |
| Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems S Arpicco, L Battaglia, P Brusa, R Cavalli, D Chirio, F Dosio, M Gallarate, ... Journal of Drug Delivery Science and Technology 32, 298-312, 2016 | 65 | 2016 |
| In yeast sterol biosynthesis the 3-keto reductase protein (Erg27p) is required for oxidosqualene cyclase (Erg7p) activity C Mo, P Milla, K Athenstaedt, R Ott, G Balliano, G Daum, M Bard Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2003 | 51 | 2003 |
| Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study F Soria, P Milla, C Fiorito, F Pisano, F Sogni, M Di Marco, V Pagliarulo, ... World journal of urology 34, 189-195, 2016 | 44 | 2016 |
| Pharmacokinetic evaluation of gemcitabine and 2′, 2′-difluorodeoxycytidine-5′-triphosphate after prolonged infusion in patients affected by different solid tumors L Cattel, M Airoldi, L Delprino, R Passera, P Milla, F Pedani Annals of Oncology 17, v142-v147, 2006 | 42 | 2006 |
| Validation of a simple and economic HPLC-UV method for the simultaneous determination of vancomycin, meropenem, piperacillin and tazobactam in plasma samples P Milla, F Ferrari, E Muntoni, M Sartori, C Ronco, S Arpicco Journal of Chromatography B 1148, 122151, 2020 | 41 | 2020 |
| Subcellular localization of oxidosqualene cyclases from Arabidopsis thaliana, Trypanosoma cruzi, and Pneumocystis carinii expressed in yeast P Milla, F Viola, SO Bosso, F Rocco, L Cattel, BM Joubert, RJ LeClair, ... Lipids 37, 1171-1176, 2002 | 38 | 2002 |
| Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies E Muntoni, E Marini, N Ahmadi, P Milla, C Ghè, A Bargoni, MT Capucchio, ... Acta diabetologica 56, 1283-1292, 2019 | 35 | 2019 |
| Intravesical thermo-chemotherapy based on conductive heat: A first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients P Milla, C Fiorito, F Soria, S Arpicco, L Cattel, P Gontero Cancer chemotherapy and pharmacology 73, 503-509, 2014 | 33 | 2014 |
| 29-Methylidene-2, 3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase M Ceruti, F Rocco, F Viola, G Balliano, P Milla, S Arpicco, L Cattel Journal of medicinal chemistry 41 (4), 540-554, 1998 | 31 | 1998 |
| Inhibition of bovine β-trypsin, human α-thrombin and porcine pancreatic β-kallikrein-B by 4′, 6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative … E Casale, C Collyer, P Ascenzi, G Balliano, P Milla, F Viola, M Fasano, ... Biophysical chemistry 54 (1), 75-81, 1995 | 31 | 1995 |
| Valproic acid, a histone deacetylase inhibitor, in combination with paclitaxel for anaplastic thyroid cancer: results of a multicenter randomized controlled phase II/III trial MG Catalano, M Pugliese, M Gallo, E Brignardello, P Milla, F Orlandi, ... International journal of endocrinology 2016, 2016 | 29 | 2016 |
| Preparation and characterization of novel poly (ethylene glycol) paclitaxel derivatives S Arpicco, B Stella, O Schiavon, P Milla, D Zonari, L Cattel International journal of pharmaceutics 454 (2), 653-659, 2013 | 25 | 2013 |
| Differential inhibition of fungal oxidosqualene cyclase by 6E and 6Z isomers of 2, 3‐epoxy‐10‐aza‐10, 11‐dihydrosqualene G Balliano, P Milla, M Ceruti, F Viola, L Carrano, L Cattel FEBS letters 320 (3), 203-206, 1993 | 23 | 1993 |
